TheProfitWatch

BCAX - Bicara Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
16.6 1.48 (8.92%) 0.0 (0.03%) 0.01 (0.05%) 0.04 (0.22%) 0.0 (0.0%) 1.95 (12.09%) --- 0.0 (0.0%)

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.5
Diluted EPS:
-0.5
Basic P/E:
-36.16
Diluted P/E:
-36.16
RSI(14) 1m:
71.87
VWAP:
18.08
RVol:

Events

Period Kind Movement Occurred At

Related News